These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Dose-related effect of nicainoprol (CAS 924) on basic electrophysiologic parameters in patients with and without diseases of the heart conduction system]. Sen S, Rettig G, Schieffer H, Bette L. Z Kardiol; 1988 Sep; 77(9):600-7. PubMed ID: 3195179 [Abstract] [Full Text] [Related]
3. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias]. Cassagneau B, Miquel JP, Puel JP, Mordant B, Kher A, Fauvel JM, Bounhoure JP. Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253 [Abstract] [Full Text] [Related]
4. Dose-related cardiac electrophysiological effects of intravenous magnesium. A double-blind placebo-controlled dose-response study in patients with paroxysmal supraventricular tachycardia. Christiansen EH, Frost L, Andreasen F, Mortensen P, Thomsen PE, Pedersen AK. Europace; 2000 Oct; 2(4):320-6. PubMed ID: 11194599 [Abstract] [Full Text] [Related]
5. Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent. Sami M, Mason JW, Peters F, Harrison DC. Am J Cardiol; 1979 Sep; 44(3):526-32. PubMed ID: 474433 [Abstract] [Full Text] [Related]
6. The electrophysiological effects of ouabain on sinus node and atrium in man. Dhingra RC, Amat-Y-Leon F, Wyndham C, Wu D, Denes P, Rosen KM. J Clin Invest; 1975 Sep; 56(3):555-62. PubMed ID: 1159073 [Abstract] [Full Text] [Related]
8. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole]. Thale J, Klein H, Shanks RG, Bender F. Z Kardiol; 1985 Apr 01; 74(4):220-7. PubMed ID: 2408392 [Abstract] [Full Text] [Related]
9. [Cardiac electrophysiologic effects of prostacyclin in man]. Terrier de La Chaise A, Brembilla-Perrot B, Clozel JP, Cherrier F, Faivre G. Arch Mal Coeur Vaiss; 1985 Aug 01; 78(8):1156-62. PubMed ID: 3935072 [Abstract] [Full Text] [Related]
10. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics. Roden DM, Reele SB, Higgins SB, Mayol RF, Gammans RE, Oates JA, Woosley RL. N Engl J Med; 1980 Apr 17; 302(16):877-82. PubMed ID: 6767186 [Abstract] [Full Text] [Related]
11. Hemodynamic and electrophysiologic effects of encainide in patients with bundle branch block. Schwartz AB, Shapiro WA, Suave MJ, Shen E, Bhandari A, Morady F, Scheinman M. Can J Cardiol; 1987 Mar 17; 3(2):75-82. PubMed ID: 3105850 [Abstract] [Full Text] [Related]
12. [Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole]. Dumoulin P, Jaillon P, Kher A, Poirier JM, Cheymol G, Valty J, Flammang D, Coumel P, Medvedowsky JL, Barnay C. Arch Mal Coeur Vaiss; 1985 Oct 17; 78 Spec No():105-9. PubMed ID: 2420299 [Abstract] [Full Text] [Related]
13. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias. Abdollah H, Brugada P, Green M, Wehr M, Wellens HJ. Am J Cardiol; 1984 Sep 01; 54(6):544-9. PubMed ID: 6433688 [Abstract] [Full Text] [Related]
14. [Intravenous and oral encainide: electrophysiological effects in patients with paroxysmal reciprocating supraventricular tachycardia]. Chimienti M, Salerno JA, Moizi M, Klersy C, Marangoni E, Previtali M, Bianchi PE, Montemartini C, Bobba P. G Ital Cardiol; 1985 May 01; 15(5):533-42. PubMed ID: 3932114 [Abstract] [Full Text] [Related]
15. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M. Indian Heart J; 1996 May 01; 48(2):133-7. PubMed ID: 8682552 [Abstract] [Full Text] [Related]
16. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation. Roden DM, Lee JT, Woosley RL, Echt DS. Circulation; 1989 Nov 01; 80(5):1247-58. PubMed ID: 2805262 [Abstract] [Full Text] [Related]
17. [Electrophysiological effects of the combined administration of digoxin and propranolol in man]. Morena H, Chaltiel MG, Denis B, Gavend M, Martin-Noël P. Arch Mal Coeur Vaiss; 1978 Oct 01; 71(10):1143-53. PubMed ID: 104687 [Abstract] [Full Text] [Related]
18. [Effect of a new class I anti-arrhythmia agent cibenzoline in patients with therapy refractory, sustained ventricular tachycardias]. Kühlkamp V, Ickrath O, Haasis R, Seipel L. Z Kardiol; 1988 Sep 01; 77(9):595-9. PubMed ID: 3195178 [Abstract] [Full Text] [Related]
19. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol. Niazi I, Naccarelli G, Dougherty A, Rinkenberger R, Tchou P, Akhtar M. J Am Coll Cardiol; 1989 Mar 15; 13(4):904-10. PubMed ID: 2494243 [Abstract] [Full Text] [Related]
20. Qualitative and quantitative comparison of the cardiac effects of encainide and its three major metabolites in the dog. Davy JM, Dorian P, Kantelip JP, Harrison DC, Kates RE. J Pharmacol Exp Ther; 1986 Jun 15; 237(3):907-11. PubMed ID: 3086540 [Abstract] [Full Text] [Related] Page: [Next] [New Search]